158 related articles for article (PubMed ID: 37549240)
1. Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model.
Kamegai N; Kim H; Suzuki Y; Fukui S; Kojima H; Maruyama S; Morgan BP; Zelek WM; Mizuno M
Clin Exp Immunol; 2023 Dec; 214(2):209-218. PubMed ID: 37549240
[TBL] [Abstract][Full Text] [Related]
2. Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal.
Iguchi D; Mizuno M; Suzuki Y; Sakata F; Maruyama S; Okada A; Okada H; Ito Y
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1732-F1746. PubMed ID: 30280601
[TBL] [Abstract][Full Text] [Related]
3. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.
Mizuno M; Ito Y; Hepburn N; Mizuno T; Noda Y; Yuzawa Y; Harris CL; Morgan BP; Matsuo S
J Immunol; 2009 Jul; 183(2):1403-12. PubMed ID: 19553534
[TBL] [Abstract][Full Text] [Related]
4. Membrane complement regulators protect against fibrin exudation increases in a severe peritoneal inflammation model in rats.
Mizuno M; Ito Y; Mizuno T; Harris CL; Suzuki Y; Okada N; Matsuo S; Morgan BP
Am J Physiol Renal Physiol; 2012 May; 302(10):F1245-51. PubMed ID: 22338087
[TBL] [Abstract][Full Text] [Related]
5. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y
Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015
[TBL] [Abstract][Full Text] [Related]
6. Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation.
Kim H; Mizuno M; Furuhashi K; Katsuno T; Ozaki T; Yasuda K; Tsuboi N; Sato W; Suzuki Y; Matsuo S; Ito Y; Maruyama S
Cytotherapy; 2014 Mar; 16(3):357-68. PubMed ID: 24364907
[TBL] [Abstract][Full Text] [Related]
7. C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis.
Ozeki T; Mizuno M; Iguchi D; Kojima H; Kim H; Suzuki Y; Kinashi H; Ishimoto T; Maruyama S; Ito Y
Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1123-F1132. PubMed ID: 33818127
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal Expression of Membrane Complement Regulators Is Decreased in Peritoneal Dialysis Patients with Infected Peritonitis.
Fukui S; Mizuno M; Tawada M; Suzuki Y; Kojima H; Matsukawa Y; Imai M; Kim H; Kinashi H; Mizutani M; Minoshima K; Maruyama S; Ito Y
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298097
[TBL] [Abstract][Full Text] [Related]
9. Anti-C5a complementary peptide ameliorates acute peritoneal injury induced by neutralization of Crry and CD59.
Mizuno T; Mizuno M; Imai M; Suzuki Y; Kushida M; Noda Y; Maruyama S; Okada H; Okada N; Matsuo S; Ito Y
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1603-16. PubMed ID: 23904221
[TBL] [Abstract][Full Text] [Related]
10. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
11. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
[TBL] [Abstract][Full Text] [Related]
12. PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1.
Zhang Y; Feng J; Wang Q; Zhao S; Xu J; Li H
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871973
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
14. High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients.
Mizuno M; Suzuki Y; Higashide K; Sei Y; Iguchi D; Sakata F; Horie M; Maruyama S; Matsuo S; Morgan BP; Ito Y
PLoS One; 2017; 12(1):e0169111. PubMed ID: 28046064
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal injury by methylglyoxal in peritoneal dialysis.
Hirahara I; Kusano E; Yanagiba S; Miyata Y; Ando Y; Muto S; Asano Y
Perit Dial Int; 2006; 26(3):380-92. PubMed ID: 16722033
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin improves peritoneal ultrafiltration and blocks complement and coagulation.
Bazargani F; Albrektsson A; Yahyapour N; Braide M
Perit Dial Int; 2005; 25(4):394-404. PubMed ID: 16022098
[TBL] [Abstract][Full Text] [Related]
18. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
[TBL] [Abstract][Full Text] [Related]
19. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Nakamura S; Niwa T
J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
[TBL] [Abstract][Full Text] [Related]
20. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
